{
    "id": "dbpedia_225_0",
    "rank": 29,
    "data": {
        "url": "https://www.yumpu.com/en/document/view/15765767/scientific-report-2010-2011-iov",
        "read_more_link": "",
        "language": "en",
        "title": "SCIENTIFIC REPORT 2010 - 2011 - IOV",
        "top_image": "https://www.yumpu.com/en/image/facebook/15765767.jpg",
        "meta_img": "https://www.yumpu.com/en/image/facebook/15765767.jpg",
        "images": [
            "https://assets.yumpu.com/release/ou6ZPgO72P294QN/v5/img/logo/Yumpu_Logo_RGB.png",
            "https://assets.yumpu.com/release/ou6ZPgO72P294QN/v5/img/account/document_privacy_modal/step1.png",
            "https://assets.yumpu.com/release/ou6ZPgO72P294QN/v5/img/account/document_privacy_modal/step2.png",
            "https://img.yumpu.com/15765767/1/500x640/scientific-report-2010-2011-iov.jpg",
            "https://assets.yumpu.com/v4/img/avatar/female-200x200.jpg",
            "https://img.yumpu.com/51243306/1/184x260/delibera-iov.jpg?quality=85",
            "https://img.yumpu.com/51186487/1/184x260/protocollo-della-comunicazione-nella-prassi-clinica-iov.jpg?quality=85",
            "https://img.yumpu.com/50530003/1/184x260/carta-servizi-iov.jpg?quality=85",
            "https://img.yumpu.com/50379919/1/184x260/scheda-unica-di-segnalazione-di-sospetta-farmacovigilanza.jpg?quality=85",
            "https://img.yumpu.com/49208948/1/184x260/radioterapia-iov.jpg?quality=85",
            "https://img.yumpu.com/46600716/1/190x135/le-lesioni-nervose-periferiche-dellarto-superiore-iov.jpg?quality=85",
            "https://img.yumpu.com/44040605/1/190x245/172-2010-iov.jpg?quality=85",
            "https://img.yumpu.com/43639800/1/190x253/a-questionnaire-to-evaluate-the-knowledge-and-attitudes-of-iov.jpg?quality=85",
            "https://img.yumpu.com/41518908/1/184x260/preparazione-alla-colonscopia-iov.jpg?quality=85",
            "https://img.yumpu.com/40854298/1/184x260/dichiarazione-sostitutiva-di-atto-di-notorieta-e-di-certificazione-iov.jpg?quality=85",
            "https://img.yumpu.com/39519505/1/190x245/85-2009-iov.jpg?quality=85",
            "https://img.yumpu.com/39457430/1/190x245/23-2008-iov.jpg?quality=85",
            "https://img.yumpu.com/38616315/1/190x245/delibera-iov.jpg?quality=85",
            "https://img.yumpu.com/37040102/1/184x260/delibera-iov.jpg?quality=85",
            "https://img.yumpu.com/36676585/1/184x260/regione-del-veneto-istituto-oncologico-veneto-iov.jpg?quality=85",
            "https://assets.yumpu.com/release/ou6ZPgO72P294QN/v5/img/logo/yumpu-footer2x.png",
            "https://assets.yumpu.com/v5/img/footer/worldmap-retina.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "ioveneto.it",
            "clinical",
            "oncology",
            "tumor",
            "melanoma",
            "departments",
            "tumors",
            "scientific",
            "molecular",
            "radiotherapy",
            "european",
            "ioveneto.it"
        ],
        "tags": null,
        "authors": [
            "Yumpu.com"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "SCIENTIFIC REPORT 2010 - 2011 - IOV",
        "meta_lang": "en",
        "meta_favicon": "https://assets.yumpu.com/release/ou6ZPgO72P294QN/v5/img/logo/icon-favicon.png",
        "meta_site_name": "yumpu.com",
        "canonical_link": "https://www.yumpu.com/en/document/view/15765767/scientific-report-2010-2011-iov",
        "text": "Page 3 and 4: FOREWORD 5 THE INSTITUTE 9 Chief Of\n\nPage 5 and 6: FOREWORD FOREWORD 5\n\nPage 7: disciplines is terrific; it is impo\n\nPage 10 and 11: The IRCCS Istituto Oncologico Venet\n\nPage 12 and 13: Map of Busonera Hospital area in th\n\nPage 14: Chief Officer Address When we start\n\nPage 17 and 18: GENERAL DIRECTORATE ADMINISTRATIVE\n\nPage 19: CLINICAL ACTIVITY ORGANIZATION CLIN\n\nPage 22 and 23: Chief Medical Officer Report Gradua\n\nPage 24 and 25: Hospitalisation 9000 8000 7000 6000\n\nPage 26 and 27: Chemotherapy courses 20000 18000 16\n\nPage 28 and 29: Multidisciplinary Groups The clinic\n\nPage 30 and 31: Peritoneal Carcinomatosis Melanoma\n\nPage 32 and 33: CLINICAL ONCOLOGY THE DEPARTMENTS S\n\nPage 34 and 35: Main Pubblications Clinical Oncolog\n\nPage 36 and 37: Mission The mission of the Unit of\n\nPage 38 and 39: Major Collaborations Multidisciplin\n\nPage 40 and 41: sequence of treatments and the role\n\nPage 42 and 43: and experimental research. Several\n\nPage 45 and 46: the influence of the function of th\n\nPage 47 and 48: Clinical and Research Staff Vanna C\n\nPage 49 and 50: Distribution of patients by cancer\n\nPage 51 and 52: aNalySiS Of ThE prOGNOSTiC aND prED\n\nPage 54 and 55:\n\nMain Pubblications Evaluation and I\n\nPage 56 and 57:\n\nThis Unit was founded in November 2\n\nPage 58 and 59:\n\nMain Pubblications Surgical Oncolog\n\nPage 60 and 61:\n\nMission The Surgical Oncology Unit\n\nPage 62:\n\nA systematic review on health-relat\n\nPage 65 and 66:\n\nClinical and Research Staff Fernand\n\nPage 67 and 68:\n\nMajor Ongoing Research Projects Int\n\nPage 69 and 70:\n\nClinical and Research Staff Nursing\n\nPage 71 and 72:\n\nClinical Areas of Excellence The Gr\n\nPage 73 and 74:\n\ndatabase where the relevant data on\n\nPage 75 and 76:\n\npositive predictive factors for res\n\nPage 77 and 78:\n\nClinical and Research Staff Giorgio\n\nPage 79 and 80:\n\n2010 Clinical Activity EGDS Esophag\n\nPage 81 and 82:\n\nin situ neoplasia to diffuse, invas\n\nPage 83:\n\nClinical and Research Staff Muzio M\n\nPage 86 and 87:\n\nMajor Ongoing Research Project a ra\n\nPage 88 and 89:\n\nMethods. The main aim of this retro\n\nPage 90 and 91:\n\nMain Pubblications Chief Prospectiv\n\nPage 92 and 93:\n\nMission The mission of the Oncologi\n\nPage 94:\n\nOther Programs and Future Perspecti\n\nPage 97 and 98:\n\nClinical and Research Staff Luigi P\n\nPage 99 and 100:\n\nMajor Research Collaborations Resea\n\nPage 101 and 102:\n\nVeneto Institute of Oncology which\n\nPage 103 and 104:\n\nmean AUC difference 0.10 0.08 0.06\n\nPage 105:\n\nfoto\n\nPage 108 and 109:\n\nRadiotherapy and Nuclear Medicine M\n\nPage 110 and 111:\n\nRiccardo Sanco Silvia Zampieri Manu\n\nPage 112 and 113:\n\nRadiotherapy Equipment Radiotherapy\n\nPage 114 and 115:\n\n125 Iodine episcleral plaque brachy\n\nPage 116 and 117:\n\nMajor Ongoing Research Projects Bor\n\nPage 118:\n\nPrograms and Future Perspectives Se\n\nPage 121 and 122:\n\nClinical and Research Staff Marta P\n\nPage 123 and 124:\n\nMajor Ongoing Research Projects The\n\nPage 125:\n\nof Medicine, seems to be a promisin\n\nPage 128 and 129:\n\nMain Pubblications Immunology and M\n\nPage 130 and 131:\n\nMission The Unit includes personnel\n\nPage 132 and 133:\n\nMajor Collaborations Inside the IOV\n\nPage 134 and 135:\n\nUnit. The Unit mission includes col\n\nPage 136 and 137:\n\nThe presence of at least one MPM ca\n\nPage 138 and 139:\n\nCervical HPV infection is very comm\n\nPage 140 and 141:\n\ntest within the same programs and t\n\nPage 142 and 143:\n\n(MLPA) technique. MLPA, contrary to\n\nPage 144 and 145:\n\nmainly by the nucleotide excision r\n\nPage 146 and 147:\n\nenabled detection of these rare can\n\nPage 148 and 149:\n\nMDSC are able to suppress the activ\n\nPage 150 and 151:\n\ntyrosine kinase proteins, account f\n\nPage 152 and 153:\n\nwhich is identifiable by anti-c-myc\n\nPage 154 and 155:\n\nMain Pubblications Hereditary Endoc\n\nPage 156 and 157:\n\nMission The mission of the Heredita\n\nPage 158 and 159:\n\nmutations confer 50% penetrance by\n\nPage 160 and 161:\n\negulatory functional variants, disr\n\nPage 162 and 163:\n\nMain Pubblications Chief Photoreact\n\nPage 164 and 165:\n\nMission The Pharmacy Unit of the IO\n\nPage 166:\n\nOther Programs and Future Perspecti\n\nPage 169 and 170:\n\nClinical and Research Staff Alberto\n\nPage 171 and 172:\n\nMajor Research in Progress Troponin\n\nPage 173 and 174:\n\nClinical and Research Staff Eleonor\n\nPage 175 and 176:\n\nMajor Ongoing Research Projects Int\n\nPage 177 and 178:\n\nPrograms and Perspectives for the F\n\nPage 179 and 180:\n\nClinical and Research Staff Adminis\n\nPage 181 and 182:\n\nas “frequent”, “irregular”\n\nPage 185:\n\nTHE RESEARCH THE RESEARCH 185\n\nPage 188 and 189:\n\nGeneral Considerations THE RESEARCH\n\nPage 190 and 191:\n\nIRCCS, in terms of both overall pro\n\nPage 192 and 193:\n\npublications of IOV researchers whi\n\nPage 194 and 195:\n\nIOV Library 2008-2011 Nilde Exchang\n\nPage 196 and 197:\n\nwould be auspicated, in the interes\n\nPage 198 and 199:\n\nACC (Alleanza Contro il Cancro); OE\n\nPage 200 and 201:\n\nItalian Association for Research on\n\nPage 202 and 203:\n\nClinical Trials and Biostatistics U\n\nPage 204 and 205:\n\nMission The main aim of the Unit is\n\nPage 206:\n\nPrograms and Perspectives for the F\n\nPage 210 and 211:\n\nStrategic Scientific Options In thi\n\nPage 212 and 213:\n\nOncology has now entered an era in\n\nPage 214 and 215:\n\nNormal tissues are organized in a h\n\nPage 216 and 217:\n\nIn the following Section we summari\n\nPage 218 and 219:\n\nLINE 1 Tumor Epidemiology and Preve\n\nPage 220 and 221:\n\nLINE 2 Mechanisms of Cancerogenesis\n\nPage 222 and 223:\n\nLINE 3 Instrumental and Molecular A\n\nPage 224 and 225:\n\nL03P22 Ruolo della 18F-FDG PET/CT n\n\nPage 226 and 227:\n\nLINE 4 Innovative Therapeutic Appro\n\nPage 228 and 229:\n\nL04P20 L04P21 L04P22 L04P23 Studio\n\nPage 230 and 231:\n\nLINE 5 Tumor Immunology and Innovat\n\nPage 232 and 233:\n\nLINE 6 Quality of Life in Cancer Pa\n\nPage 234 and 235:\n\nL06P21 La dimensione religiosa e l\n\nPage 236 and 237:\n\nEthics Committee The IOV Ethics Com\n\nPage 238 and 239:\n\nA phase III trial of Vinflunine + C\n\nPage 240 and 241:\n\nLYMPHOMAS A 3 arm multicenter phase\n\nPage 242 and 243:\n\nRandomised double blind clinical tr\n\nPage 245 and 246:\n\nVENETO ONCOLOGY NETWORK VENETO ONCO\n\nPage 247 and 248:\n\nOspedale classificato ed equiparato\n\nPage 249 and 250:\n\nEDUCATION EDUCATION 249\n\nPage 251 and 252:\n\nIntegrative Oncology Care G. Opoche\n\nPage 253 and 254:\n\nAggiornamento delle linee guida sul\n\nPage 255 and 256:\n\nDOCTOraTE SChOOl iN ONCOlOGy aND Su\n\nPage 257 and 258:\n\n2009 Barbara Seliger How tumor cell\n\nPage 259:\n\nGenoveffa Franchini HTLV-1, the smo\n\nPage 263:\n\nAwards In November 2010 Dr. Giulia\n\nPage 266 and 267:\n\n2009 PUBLICATIONS / Journals indexe\n\nPage 268 and 269:\n\nMGMT promoter methylation status. J\n\nPage 270 and 271:\n\nexperience. Lung Cancer; 68:2; 228-\n\nPage 272 and 273:\n\n98 Mandruzzato S, Solito S, Falisi\n\nPage 274 and 275:\n\npathway biomarker. Clinical Colorec\n\nPage 276 and 277:\n\nates of adrenal surgery: Analysis o\n\nPage 278 and 279:\n\n17 Savastano S, Vecchiato M, Sarzo\n\nPage 280 and 281:\n\nfrom Italian cancer registries. Dig\n\nPage 282 and 283:\n\nof women with atypical squamous cel\n\nPage 284 and 285:\n\na new approach to an old question.\n\nPage 286 and 287:\n\n112 Mescoli C, Castoro C, Sergio A,\n\nPage 288 and 289:\n\nInvestigators, Spurdle A B, Holland\n\nPage 290 and 291:\n\nsurgery. Psycho-oncology; 20:7; 706\n\nPage 292 and 293:\n\n2011 PUBLICATIONS / Journals indexe\n\nPage 294 and 295:\n\n27 Castelblanco E, Gallel P, Ros S,\n\nPage 296 and 297:\n\nchildren. Clinical and experimental\n\nPage 298 and 299:\n\nU, Hogervorst F B, Kriege M, van de\n\nPage 300 and 301:\n\nhas stopped increasing. Epidemiolog\n\nPage 302 and 303:\n\n137 Trojniak M P, Palozzo A C, Mazu\n\nPage 305 and 306:\n\nINDEX INDEX 305\n\nPage 307 and 308:\n\nGranziera Elisa 83, 86-87 Gregianin\n\nPage 309 and 310:\n\nImmunotherapy 130, 133, 151, 200, 2"
    }
}